Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 600-386-6 | CAS number: 10305-38-1
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 02 Feb 2011 - 26 Feb 2011
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP - Guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2011
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- adopted in 1992
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The LLNA method was not available yet by the time the study was conducted.
Test material
- Reference substance name:
- 3-(hexyloxy)propane-1,2-diol
- EC Number:
- 600-386-6
- Cas Number:
- 10305-38-1
- Molecular formula:
- C9H20O3
- IUPAC Name:
- 3-(hexyloxy)propane-1,2-diol
- Details on test material:
- - Name of test material (as cited in study report): SDX-3096
- Physical state: liquid
- Analytical purity: ≥99%
- Lot/batch No.: 00711
- Expiration date of the lot/batch: Jan 2012
- Stability under test conditions: high temperature should be avoided. Stable at storage conditions
- Storage condition of test material: room temperature (18 to 22 °C)
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Kwl:Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Kiwa Laboratory Animals Co., Ltd, Japan
- Age at study initiation: 6 weeks
- Weight at study initiation: 318-398 g
- Housing: stainless-steel wire-mesh cages (W 266 x D 266 x H 200 mm: Riko Denki Co., Ltd.). The animals were housed in groups of 2 or individually during the study
- Diet: pelleted diet RC4 (Oriential Yeast Co., Ltd., Lot No.; 101116) was provided ad libitum
- Water: tap water (Fujimi Water Union) was provided ad libitum via an automatic water supply system
- Acclimation period: 14 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-24
- Humidity (%): 40-76
- Air changes (per hr): 11-14
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- water
- Concentration / amount:
- First induction (intradermal): 0.5%
Second induction (epicutaneous): 100%
Challenge: 25 and 10%
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- First induction (intradermal): 0.5%
Second induction (epicutaneous): 100%
Challenge: 25 and 10%
- No. of animals per dose:
- 5 (controls), 10 (in test group)
- Details on study design:
- RANGE FINDING TESTS:
Preliminary test 1 (for determination of the concentration for intradermal induction): Two guinea pigs were injected intradermally with 0.1 mL (midline of the shaved shoulder region) of the test substance at concentrations of 10, 5, 2.5, 1, 0.5 and 0.25% (six sites, three of each on the left and right side of the midline of the shaved shoulder region).
Preliminary test 2 (for determination of the concentrations for topical induction and challenge): For topical applications, 0.1 mL of the test substance at concentrations of 100, 50, 25, 10, 5 and 2.5% were applied to four further animals. The animals were wrapped with occlusive dressing for 24 hours.
The skin reactions were then evaluated at 24 and 48 hours after intradermal injection and 24 and 48 hours after patch removal according to the evaluation standard of skin reaction by Magnusson and Kligman.
The following concentrations were chosen for the main study based on the results of this preliminary study: The concentrations for the intradermal induction was selected as 0.5% as this was the highest concentration that did not produce necrosis at the intradermal injection sites. The concentrations for the epicutaneous induction was selected at 100%, as it was the highest concentration that produced slight skin reactions at the topical application sites. For the challenge induction, the maximum no-irritation concentration of 25% and approximately its ½ of 10% were selected.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2 (intradermal and epicutaneous, respectively)
- Exposure period: single injection (intradermal) and 48 h (epicutaneous)
- Test groups:
Intradermal (3 pairs of 0.1 mL injections):
Injection 1: a 1:1 mixture of FCA/water
Injection 2: 0.5% of test substance
Injection 3: a 1:1 mixture of 1% test susbtance/FCA
Epicutaneous: 0.2 mL of 100% test substance
- Control group:
Intradermal (3 pairs of 0.1 mL injections):
Injection 1: a 1:1 mixture of FCA/water
Injection 2: water
Injection 3: a 1:1 mixture of FCA/water
- Site: shoulder region
- Frequency of applications: every 7 days
- Duration: 0-8 days
- Concentrations: 0.5% intradermal and 100% epicutaneous
B. CHALLENGE EXPOSURE
- No. of exposures: one
- Day(s) of challenge: day 20
- Exposure period: 24 h
- Test and control groups: 0.1 mL of the 25 and 10% test substance
- Site: flank
- Concentrations: 25 and 10%
- Evaluation (hr after challenge): 24 and 48 - Challenge controls:
- The control group is actually a challenge control.
- Positive control substance(s):
- yes
- Remarks:
- 1-Chloro-2,4-dinitrobenzene (DNCB)
Results and discussion
- Positive control results:
- The positive control substance (0.1% DNCB in acetone) induced positive reactions in 5/5 animals (100%) at 24 and 48 hours after challenge patch removal. On the other hand, the sensitisation rates for the acetone challenge sites were determined to be 0% at 24 and 48 hours after challenge patch removal.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- induction intradermal: 0; challenge; 25%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: induction intradermal: 0; challenge; 25%. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- induction intradermal: 0%; challenge: 10%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: induction intradermal: 0%; challenge: 10%. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- induction intradermal: 0.5%; challenge: 25%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: induction intradermal: 0.5%; challenge: 25%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- induction intradermal: 0.5%; challenge: 10%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: induction intradermal: 0.5%; challenge: 10%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- induction intradermal: 0.1%; challenge: 0.1%
- No. with + reactions:
- 5
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: positive control. Dose level: induction intradermal: 0.1%; challenge: 0.1%. No with. + reactions: 5.0. Total no. in groups: 5.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- induction intradermal: 0%; challenge: 25%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: induction intradermal: 0%; challenge: 25%. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- induction intradermal: 0; challenge: 10%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: induction intradermal: 0; challenge: 10%. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- induction intradermal: 0.5%; challenge: 25%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: induction intradermal: 0.5%; challenge: 25%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- induction intradermal: 0.5%; challenge: 10%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: induction intradermal: 0.5%; challenge: 10%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- induction intradermal: 0.1%; challenge: 0.1%
- No. with + reactions:
- 5
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: positive control. Dose level: induction intradermal: 0.1%; challenge: 0.1%. No with. + reactions: 5.0. Total no. in groups: 5.0.
Any other information on results incl. tables
Table 3. Mean skin reaction scores
Test group |
Substance for induction |
Substance for challenge |
Score of skin reactions |
No. of animals |
No. of animals with positive reactions |
Sensitisation rate (%) |
||
Intradermal (concentration) |
Topical (concentration) |
(concentration) |
24 ha) |
48 hb) |
||||
Test substance sensitisation group |
Test substance in water (0.5%) |
Test substance (100%) |
Test substance in water (25%) |
0 |
10 |
10 |
0/10 |
0 |
1 |
0 |
0 |
||||||
2 |
0 |
0 |
||||||
3 |
0 |
0 |
||||||
Mean score |
0 |
0 |
||||||
Test substance in water (10%) |
0 |
10 |
10 |
0/10 |
0 |
|||
1 |
0 |
0 |
||||||
2 |
0 |
0 |
||||||
3 |
0 |
0 |
||||||
Mean score |
0 |
0 |
||||||
Water |
0 |
10 |
10 |
0/10 |
0 |
|||
1 |
0 |
0 |
||||||
2 |
0 |
0 |
||||||
3 |
0 |
0 |
||||||
Mean score |
0 |
0 |
||||||
Control group |
Water |
Water |
Test substance in water (25%) |
0 |
5 |
5 |
0/5 |
0 |
1 |
0 |
0 |
||||||
2 |
0 |
0 |
||||||
3 |
0 |
0 |
||||||
Mean score |
0 |
0 |
||||||
Test substance in water (10%) |
0 |
5 |
5 |
0/5 |
0 |
|||
1 |
0 |
0 |
||||||
2 |
0 |
0 |
||||||
3 |
0 |
0 |
||||||
Mean score |
0 |
0 |
||||||
Water |
0 |
5 |
5 |
0/5 |
0 |
|||
1 |
0 |
0 |
||||||
2 |
0 |
0 |
||||||
3 |
0 |
0 |
||||||
Mean score |
0 |
0 |
||||||
Positive control substance sensitisation group |
0.1% DNCB in olive oil |
0.1% DNCB in olive oil |
0.1% DNCB in acetone |
0 |
0 |
0 |
5/5 |
100 |
1 |
0 |
0 |
||||||
2 |
0 |
0 |
||||||
3 |
5 (3)c) |
5 (3)c) |
||||||
Mean score |
3 |
3 |
0/5 |
0 |
||||
|
Acetone |
0 |
5 |
5 |
||||
1 |
0 |
0 |
||||||
2 |
0 |
0 |
||||||
3 |
0 |
0 |
||||||
Mean score |
0 |
0 |
||||||
a) Hours after removal of the patch for challenge
b) The number of animals with individual score of 1 or above
c) The number of animals revealed escher formation
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- CLP: not classified
DSD: not classified
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
